A Decade-Long Journey to Ask Whether “Less Can Be More” in Metastatic Colorectal Cancer Treatment
More than ten years ago, we began the C-cubed trial with an important question: can some patients with metastatic colorectal cancer live just as long while starting with a gentler treatment? Our study explored whether delaying oxaliplatin could preserve quality of life without compromising survival.
